Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Svatava Merkle
Institutions:
Cincinnati Children's Hospital Medical Center,
University of Cincinnati
Observed institutions:
Cincinnati Children's Hospital Medical Center,
University of Minnesota,
University of Cincinnati,
University of Cincinnati Medical Center
ORCID:
0000-0001-7604-3849
Observed ORCID:
0000-0001-7604-3849
OpenAlex ID:
A5020642863
RAS Pathway Mutations and Therapeutics in Vascular Anomalies
2025
·
Sara Alharbi
, Svatava Merkle
, et al.
·
Pediatric Blood & Cancer
·
15
PDF
Major Adverse Events With Chimeric Antigen Receptor T-Cell Therapy: Presentation, Diagnosis, and Resuscitation
2025
·
Kiril Dimitrov
, Florian Merkle
, et al.
·
Annals of Emergency Medicine
·
11
PDF
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation
2024
·
Marketa Dimitrov
, Svatava Merkle
, et al.
·
Transplantation and Cellular Therapy
·
9
Trametinib Normalizes Angiopoietin-2 Levels and Successfully Treats Kaposiform Lymphangiomatosis
2025
·
C. Griffin McDaniel
, Svatava Merkle
, et al.
·
Journal of Vascular Anomalies
·
4
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRAS Q61R Human Endothelial Cells
2026
·
Sara Alharbi
, Andrew Wagner
, et al.
·
Pediatric Blood & Cancer
·
3
Unusual foreign body aspiration in a 4‐year‐old patient
2024
·
Florian Merkle
, Travis D. Olives
, et al.
·
Journal of the American College of Emergency Physicians Open
·
2
RAS Inhibitor RMC ‐7977 Blocks Vascular Overgrowth of NRAS Q61R Mutant Endothelial Cells
2026
·
Sara Alharbi
, Svatava Merkle
, et al.
·
Journal of Cellular and Molecular Medicine
·
1
Sirolimus outperforms alpelisib in models of NRASQ61R-driven vascular overgrowth
2026
·
Svatava Merkle
, Sara Alharbi
, et al.
·
Blood Vessels Thrombosis & Hemostasis
PDF
Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus
2026
·
Svatava Merkle
, Kiersten Ricci
, et al.
·
Pediatric Blood & Cancer
Use of angiopoietin-2 as a biomarker in vascular anomalies beyond complex lymphatic anomalies
2025
·
Svatava Merkle
, Timothy LeCras
, et al.
·
Blood
PDF
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide Expedites Donor-Derived Immune Reconstitution in a Pediatric Severe Aplastic Anemia Cohort
2023
·
Marketa Dimitrov
, Svatava Merkle
, et al.
·
Blood
Radiation Sparing Reduced Intensity Conditioning for Allogeneic Cell Transplantation in Patients with Dyskeratosis Congenita Comparable to Standard of Care: A Phase III Single Institution Trial
2022
·
Marketa Dimitrov
, Svatava Merkle
, et al.
·
Blood
Faculty Opinions recommendation of IL33 is a key driver of treatment resistance of cancer.
2020
·
Jakub Tolar
, Svatava Merkle
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Show more works
View as search
Works count:
13
Citation count:
45
H-index:
4
I10-index:
2
Year
Topic
Type